Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

monarch energy ltd (MNL) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MONARCH ENERGY LTD (MNL)

Related News

No related news articles were found.

monarch energy ltd (MNL) Related Businessweek News

No Related Businessweek News Found

monarch energy ltd (MNL) Details

ChroMedX Corp., a medical technology company, engages in the research, development, and manufacture of in vitro diagnostics and point-of-care technologies. The company offers medical devices for point of care testing, blood sample collection, and serum/plasma treatment and analysis. It provides HemoPalm, a blood analysis system that integrates blood gases, electrolytes, and CO-oximetry in one hand-held analyzer; and Automated UltraFiltration cartridge provides a sample preparation method, which is used for the measurement of free therapeutic drugs and hormones through the immunoassays. The company is headquartered in Toronto, Canada.

monarch energy ltd (MNL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

monarch energy ltd (MNL) Key Developments

ChroMedX Corp. Appoints Robert Smyth to Technical Advisory Board

ChroMedX Corp. announced the appointment of anesthesiologist Dr. Robert Smyth to the company's Technical Advisory Board.

ChroMedX Corp. Announces Filing of Second Us Provisional Patent Application Pertaining to HemoPalm Cartridge and Analyzer System

ChroMedX Corp. announced the filing of a second US Provisional Patent Application pertaining to the HemoPalm Cartridge and Analyzer system. The second US Provisional Patent Application No. 62/114,700 entitled ‘Joint Spectroscopic and Biosensor System for Point-of-Care Testing’ was filed on February 11, 2015, and describes recently developed aspects of the company's HemoPalm Cartridge and Analyzer system. The first US Provisional Patent Application No. 62/006,066 was filed on May 31, 2014. In May 2015, an international patent application (PCT) will be filed, claiming priority to the two US Provisional Patent Applications. This PCT has the potential to effectively extend the lifespan of its issued US Patent pertaining to HemoPalm, and to provide patent protection outside the US, in particular Europe, China and India.

ChroMedX Corp. Auditor Raises 'Going Concern' Doubt

ChroMedX Corp. filed its Annual on Jan 28, 2015 for the period ending Sep 30, 2014. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNL:CN C$0.00 CAD 0.00

MNL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MNL.
View Industry Companies

Industry Analysis


Industry Average

Valuation MNL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MONARCH ENERGY LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at